Sirona Biochem Corp Stock Today
| SBM Stock | CAD 0.08 0.01 6.67% |
Performance9 of 100
| Odds Of DistressLess than 50
|
Sirona Biochem is selling for under 0.08 as of the 25th of November 2024; that is 6.67% increase since the beginning of the trading day. The stock's lowest day price was 0.07. Sirona Biochem has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Sirona Biochem Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of December 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. SIRONA BIOCHEM operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.. The company has 258.84 M outstanding shares of which 93.61 K shares are at this time shorted by private and institutional investors with about 1.51 days to cover all short positions. More on Sirona Biochem Corp
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Sirona Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sirona Biochem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sirona Biochem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Iron (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Iron, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Sirona Biochem's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sirona Biochem's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSirona Biochem can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sirona Biochem's financial leverage. It provides some insight into what part of Sirona Biochem's total assets is financed by creditors.
| |||||
Sirona Biochem Corp (SBM) is traded on TSX Venture Exchange in Canada and employs 4 people. Sirona Biochem is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.71 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sirona Biochem's market, we take the total number of its shares issued and multiply it by Sirona Biochem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sirona Biochem Corp classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 258.84 M outstanding shares of which 93.61 K shares are at this time shorted by private and institutional investors with about 1.51 days to cover all short positions.
Sirona Biochem Corp has accumulated about 376.43 K in cash with (1.76 M) of positive cash flow from operations.
Check Sirona Biochem Probability Of Bankruptcy
Ownership AllocationSirona Biochem Corp shows a total of 258.84 Million outstanding shares. Sirona Biochem Corp has 10.56 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sirona Ownership Details
Sirona Biochem Corp Risk Profiles
Although Sirona Biochem's alpha and beta are two of the key measurements used to evaluate Sirona Biochem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 8.56 | |||
| Semi Deviation | 7.49 | |||
| Standard Deviation | 12.34 | |||
| Variance | 152.4 |
Sirona Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sirona Biochem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Sirona Biochem Corporate Management
Elected by the shareholders, the Sirona Biochem's board of directors comprises two types of representatives: Sirona Biochem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sirona. The board's role is to monitor Sirona Biochem's management team and ensure that shareholders' interests are well served. Sirona Biochem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sirona Biochem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CGA | CFO Director | Profile | |
| Graldine DeliencourtGodefroy | Chief Director | Profile | |
| Michelle MBA | VP Operations | Profile | |
| Brett Premack | Scientific Consultant | Profile |
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.